Evidence map›Paper›PMID 32050297›Full record

ReviewAging cell2020

Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.

Bianca Marchetti, Cataldo Tirolo, Francesca L'Episcopo, Salvatore Caniglia, Nunzio Testa, Jayden A Smith, Stefano Pluchino, Maria F Serapide

Open access · goldAbstract readReview
In one paragraph

Review in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Quo Vadis translational neuroscience?Translational neuroscience · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. New Approaches to the Treatment of Alzheimer's Disease.Pharmaceuticals (Basel, Switzerland) · 2025
    Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bianca MarchettiDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), Pharmacology and Physiology Sections, Medical School, University of Catania, Catania, Italy.ORCID 0000-0002-9287-8448
Cataldo TiroloNeuropharmacology Section, OASI Research Institute-IRCCS, Troina, Italy.ORCID 0000-0003-1747-8134
Francesca L'EpiscopoNeuropharmacology Section, OASI Research Institute-IRCCS, Troina, Italy.ORCID 0000-0003-3292-9677
Salvatore CanigliaNeuropharmacology Section, OASI Research Institute-IRCCS, Troina, Italy.ORCID 0000-0002-9416-8458
Nunzio TestaNeuropharmacology Section, OASI Research Institute-IRCCS, Troina, Italy.ORCID 0000-0002-4024-2325
Jayden A SmithDepartment of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0003-2307-8452
Stefano PluchinoDepartment of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6267-9472
Maria F SerapideDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), Pharmacology and Physiology Sections, Medical School, University of Catania, Catania, Italy.ORCID 0000-0001-6332-4772
Oasi Maria SS · ITUniversity of Cambridge · GBUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A common hallmark of age-dependent neurodegenerative diseases is an impairment of adult neurogenesis. Wingless-type mouse mammary tumor virus integration site (Wnt)/β-catenin (WβC) signalling is a vital pathway for dopaminergic (DAergic) neurogenesis and an essential signalling system during embryonic development and aging, the most critical risk factor for Parkinson's disease (PD). To date, there is no known cause or cure for PD. Here we focus on the potential to reawaken the impaired neurogenic niches to rejuvenate and repair the aged PD brain. Specifically, we highlight WβC-signalling in the plasticity of the subventricular zone (SVZ), the largest germinal region in the mature brain innervated by nigrostriatal DAergic terminals, and the mesencephalic aqueduct-periventricular region (Aq-PVR) Wnt-sensitive niche, which is in proximity to the SNpc and harbors neural stem progenitor cells (NSCs) with DAergic potential. The hallmark of the WβC pathway is the cytosolic accumulation of β-catenin, which enters the nucleus and associates with T cell factor/lymphoid enhancer binding factor (TCF/LEF) transcription factors, leading to the transcription of Wnt target genes. Here, we underscore the dynamic interplay between DAergic innervation and astroglial-derived factors regulating WβC-dependent transcription of key genes orchestrating NSC proliferation, survival, migration and differentiation. Aging, inflammation and oxidative stress synergize with neurotoxin exposure in "turning off" the WβC neurogenic switch via down-regulation of the nuclear factor erythroid-2-related factor 2/Wnt-regulated signalosome, a key player in the maintenance of antioxidant self-defense mechanisms and NSC homeostasis. Harnessing WβC-signalling in the aged PD brain can thus restore neurogenesis, rejuvenate the microenvironment, and promote neurorescue and regeneration.

Indexed as

NeurogenesisWnt Signaling Pathway1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAgingAnimalsAstrocytesDopaminergic NeuronsHumansLateral VentriclesMicrogliaNeural Stem CellsNeuronal PlasticityParkinson DiseaseParkinsonian Disorders1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineadult neurogenesisagingneuroinflammationParkinson's diseaseplasticity/self-repairWnt/β-catenin signalling

Identifiers

PMID32050297
PMCPMC7059166
OpenAlexW3006053188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.